Sort
27,075 grants matching “cholesterol”
Using FRET to Probe the Spatial Distributions of CD4, CXCR4 and CCR5 on Membrane
$502,412Tian Jin · Niaid Extramural Activities · Z01 · FY2007 · AI
Oxidized Lipids and Endotoxemia in Vascular Inflammation
$502,328Yury Miller · La Jolla Institute For Immunology · P01 · FY2012 · HL
Regulation of Store-Operated Calcium Entry During Muscle Aging
$502,318Noah Weisleder · Ohio State University · R01 · FY2021 · AG
IMPLEMENTING MULTICOMPONENT INTERVENTIONS TO TREAT BLOOD DONORS WITH FAMILIAL HYPERCHOLESTEROLEMIA
$502,305Amit Khera · Ut Southwestern Medical Center · R33 · FY2025 · HL
Multiscale Analysis of Inter-Clock Communication
$502,288John B Hogenesch · University Of Pennsylvania · R01 · FY2011 · HL
NgBR as a regulator of endothelial function
$502,248William C. Sessa · Yale University · R01 · FY2016 · HL
PCSK9, Lipoprotein receptors, and Atherosclerosis
$502,190Sergio Fazio · Vanderbilt University · R01 · FY2012 · HL
Scavenger Receptors: Ligand Binding and Pathophysiology
$502,144Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2010 · HL
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIV
$502,121Gerald Samuel Bloomfield · Duke University · R01 · FY2022 · MD
Nurse Model in Black Families at Risk for Heart Disease
$501,972Johns Hopkins University · R01 · FY2002 · NR
Engineering a Human Skeletal Muscle Tissue Model of LGMD2B
$501,861Nenad Bursac · Duke University · R01 · FY2024 · AR
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2023 · HL
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
$501,779Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
Effect of Lipids on Vascular Graft Healing
$501,719Linda M Graham · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL
Gastrointestinal safety and therapeutics of oil-based Phosphatidylcholine-NSAIDS
$501,617Lenard M Lichtenberger · Plx Opco, Inc. · R42 · FY2008 · DK
Role of particle surface functionalization in inflammation
$501,607Andrij Holian · University Of Montana · R01 · FY2024 · ES
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2022 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Preetha Shridas · University Of Kentucky · R01 · FY2023 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2021 · HL
Mechanisms regulating the atherogenic activities of serum amyloid A
$501,577Lisa R Tannock · University Of Kentucky · R01 · FY2020 · HL
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$501,518Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2015 · HL
Regulation of Renal Phosphate Transport by Lipids
$501,379Moshe Levi · University Of Colorado Denver · R01 · FY2010 · DK
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis
$501,372Karin E. Bornfeldt · University Of Washington · P01 · FY2024 · HL
Caspase-1 Activation by the Inflammasomes
$501,365Emad S. Alnemri · Thomas Jefferson University · R01 · FY2015 · AR
Atheroprotective Gene Therapy
$501,319David A Dichek · University Of Washington · R01 · FY2014 · HL